Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
Black
K J
KJ
Racette
B
B
Perlmutter
J S
JS
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003286:Contracture / Q000517:prevention & control*; D004421:Dystonia / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D010302:Parkinson Disease, Secondary / Q000188:drug therapy / Q000628:therapy; D026741:Physical Therapy Modalities; D011618:Psychotic Disorders / Q000188:drug therapy
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins; D006220:Haloperidol